Botulinum neurotoxin type A resistance: An emerging problem скачать в хорошем качестве

Botulinum neurotoxin type A resistance: An emerging problem

Botulinum neurotoxin A (BoNT-A), more commonly known as Botox, is used to treat medical conditions including dystonia and spasticity. It’s also increasingly used in cosmetic procedures. However, when used long-term or in high doses, immunoresistance is a real danger. A panel of experts is working together to increase awareness of these dangers, allowing patients to make informed treatment decisions. ━━━━━━━━━━━━━━━━━━━━ Article ──────────────────────────── https://researchoutreach.org/articles... ━━━━━━━━━━━━━━━━━━━━ Additional Information ──────────────────────────── https://cosmeticmedicinecentre.com.au... Dingley, M, et al, (2022) Emerging trends in botulinum neurotoxin A resistance: An international multidisciplinary review and consensus. Plastic and Reconstructive Surgery-Global Open, 10(6), e4407. https://journals.lww.com/prsgo/Fullte... Park, JY, et al, (2020) Neurotoxin impurities: A review of threats to efficacy. Plastic and Reconstructive Surgery-GlobalOpen, 8(1), e2627. https://journals.lww.com/prsgo/Fullte.... Kerscher, M, et al, (2019) Incobotulinumtoxin A: A highlypurified and precisely manufactured botulinum neurotoxintype A. Journal of Drugs in Dermatology, 18(1), 52–57. Jankovic, J, (2004) Botulinum toxin in clinical practice. Journal of Neurology, Neurosurgery and Psychiatry, 75(7),951–957. https://jnnp.bmj.com/content/75/7/951 ━━━━━━━━━━━━━━━━━━━━ Research Outreach ──────────────────────────── https://researchoutreach.org/   / @resoutreach     / researchoutreach   ━━━━━━━━━━━━━━━━━━━━ #neurotoxin #science #antibodies ━━━━━━━━━━━━━━━━━━━━